Explore how sexually transmitted infections progress, symptoms to watch for, and prevention strategies to protect sexual ...
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...
ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...
Could a social media post really solve years of confusion? Friedrich's Ataxia is a rare disease that only affects 1-in-50,000 people. "Looking at the way this girl moved — the unsteadiness and ...
A new study, led by experts at the University of Nottingham, has found that patients who need treatment for neurological and mental health disorders, would favour non-invasive neuromodulation ...
Tetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily ...
A new study, led by experts at the University of Nottingham, has found that patients who need treatment for neurological and mental health disorders, would favour non-invasive neuromodulation ...
A higher comorbidity burden was linked to an increased rate of adverse events as well as early discontinuation among patients ...
A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI).
In “Doctored,” Charles Piller uncovers evidence that many important Alzheimer’s studies are based on faulty data.
A study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback